0
Your cart

Your cart is empty

Books > Law > Laws of other jurisdictions & general law > Social law

Buy Now

Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Paperback, New ed.) Loot Price: R1,269
Discovery Miles 12 690
Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Paperback, New ed.):...

Intellectual Property, Pharmaceuticals and Public Health - Access to Drugs in Developing Countries (Paperback, New ed.)

Kenneth C. Shadlen, Samira Guennif, Alenka Guzman, Narayanan Lalitha

 (sign in to rate)
Loot Price R1,269 Discovery Miles 12 690 | Repayment Terms: R119 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

'Since the 1970s the pharmaceutical industry has undergone significant changes in its research and development paradigm, trade and production. Regulatory frameworks have also changed substantially, particularly in the area of intellectual property rights. This book provides much needed empirical evidence on the impact of these and other changes on the pharmaceutical sector and on access to medicines in developing countries. The studies, conducted with a common methodology, on nine developing countries (including major producers of pharmaceuticals such as China and India) and on Canada, make an outstanding contribution to the literature in the field. The data and analysis in the book are of immediate interest to policy makers and to scholars in various fields, including innovation economics, industrial policy, health systems and intellectual property.' - Carlos Correa, University of Buenos Aires, Argentina This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

General

Imprint: Edward Elgar Publishing Ltd
Country of origin: United Kingdom
Release date: May 2013
Editors: Kenneth C. Shadlen • Samira Guennif • Alenka Guzman • Narayanan Lalitha
Dimensions: 234 x 156mm (L x W)
Format: Paperback
Pages: 352
Edition: New ed.
ISBN-13: 978-0-85793-879-4
Categories: Books > Law > Laws of other jurisdictions & general law > Social law > General
Books > Medicine > General issues > Public health & preventive medicine > General
Books > Law > Laws of other jurisdictions & general law > Private, property, family law > Personal property law > Intellectual property, copyright & patents
LSN: 0-85793-879-7
Barcode: 9780857938794

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners